ANL
Price
$1.50
Change
-$0.00 (-0.00%)
Updated
Jul 18 closing price
Capitalization
55.35M
17 days until earnings call
RIGL
Price
$19.28
Change
+$0.48 (+2.55%)
Updated
Jul 21, 10:42 AM (EDT)
Capitalization
336M
Interact to see
Advertisement

ANL vs RIGL

Header iconANL vs RIGL Comparison
Open Charts ANL vs RIGLBanner chart's image
Adlai Nortye
Price$1.50
Change-$0.00 (-0.00%)
Volume$4.45K
Capitalization55.35M
Rigel Pharmaceuticals
Price$19.28
Change+$0.48 (+2.55%)
Volume$800
Capitalization336M
ANL vs RIGL Comparison Chart in %
Loading...
ANL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANL vs. RIGL commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANL is a Hold and RIGL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (ANL: $1.50 vs. RIGL: $18.80)
Brand notoriety: ANL and RIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANL: 47% vs. RIGL: 68%
Market capitalization -- ANL: $55.35M vs. RIGL: $336M
ANL [@Biotechnology] is valued at $55.35M. RIGL’s [@Biotechnology] market capitalization is $336M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANL’s FA Score shows that 1 FA rating(s) are green whileRIGL’s FA Score has 0 green FA rating(s).

  • ANL’s FA Score: 1 green, 4 red.
  • RIGL’s FA Score: 0 green, 5 red.
According to our system of comparison, ANL is a better buy in the long-term than RIGL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANL’s TA Score shows that 4 TA indicator(s) are bullish while RIGL’s TA Score has 4 bullish TA indicator(s).

  • ANL’s TA Score: 4 bullish, 1 bearish.
  • RIGL’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ANL is a better buy in the short-term than RIGL.

Price Growth

ANL (@Biotechnology) experienced а -6.80% price change this week, while RIGL (@Biotechnology) price change was -0.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

ANL is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RIGL($336M) has a higher market cap than ANL($55.4M). RIGL YTD gains are higher at: 11.772 vs. ANL (-44.138).
ANLRIGLANL / RIGL
Capitalization55.4M336M16%
EBITDAN/A48.5M-
Gain YTD-44.13811.772-375%
P/E RatioN/A9.00-
RevenueN/A203M-
Total CashN/A77.1M-
Total DebtN/A61.1M-
FUNDAMENTALS RATINGS
RIGL: Fundamental Ratings
RIGL
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
99
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANLRIGL
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
80%
Momentum
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 20 days ago
82%
Bullish Trend 12 days ago
84%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
82%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
ANL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RGBPP0.100.03
+52.17%
Regen Biopharma, Inc.
KPGHF7.630.16
+2.10%
Kelly Partners Group Holdings Ltd.
RAFLF0.75N/A
N/A
Raffles Medical Group Ltd.
VIORF0.09N/A
-0.56%
VIOR INC.
TDHOY11.10-0.24
-2.16%
T&D Holdings, Inc.

ANL and

Correlation & Price change

A.I.dvisor tells us that ANL and NVCT have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANL and NVCT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANL
1D Price
Change %
ANL100%
N/A
NVCT - ANL
22%
Poorly correlated
-1.89%
LENZ - ANL
21%
Poorly correlated
-2.43%
JAZZ - ANL
21%
Poorly correlated
-2.77%
RIGL - ANL
20%
Poorly correlated
-0.58%
FTRE - ANL
20%
Poorly correlated
-5.25%
More

RIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, RIGL has been closely correlated with CLNN. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if RIGL jumps, then CLNN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RIGL
1D Price
Change %
RIGL100%
-0.58%
CLNN - RIGL
92%
Closely correlated
-2.05%
PHIO - RIGL
84%
Closely correlated
+0.82%
AZTR - RIGL
84%
Closely correlated
-0.22%
IMRN - RIGL
82%
Closely correlated
-9.52%
DNLI - RIGL
42%
Loosely correlated
-3.65%
More